About this episode
Ian Thomson from Ypsomed and Roman Mathias from Lonza discuss the market trends in injectable delivery devices, their manufacturing process, and their future in sustainable pharma. Injectable devices offer various benefits, including improved convenience, accuracy, and safety, allowing for precise dosing while reducing the need for hospital visits.
Get every episode summarized
Each time A view on publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from A view on
Episode 10: A View On Manufacturing Hard-to-manufacture Molecules
A view on
Mar 30, 202614:14failed
Episode 9: A View On Innovating Drug Development and Manufacturing
A view on
Dec 15, 202517:15pending
Episode 8: A View On Process Analytical Technologies
A view on
Nov 11, 202518:32pending
Episode 7: A View On Spray-Drying mRNA-based Therapies
A view on
Jul 28, 202523:23pending